chr16-31084999-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001039503.3(PRSS53):c.1060G>A(p.Val354Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,583,808 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039503.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS53 | NM_001039503.3 | c.1060G>A | p.Val354Ile | missense_variant | 8/11 | ENST00000280606.7 | NP_001034592.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS53 | ENST00000280606.7 | c.1060G>A | p.Val354Ile | missense_variant | 8/11 | 1 | NM_001039503.3 | ENSP00000280606 | P1 | |
PRSS53 | ENST00000486499.1 | n.3927G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000240 AC: 50AN: 208728Hom.: 1 AF XY: 0.000274 AC XY: 31AN XY: 113188
GnomAD4 exome AF: 0.000265 AC: 380AN: 1431462Hom.: 4 Cov.: 33 AF XY: 0.000305 AC XY: 216AN XY: 709204
GnomAD4 genome AF: 0.000223 AC: 34AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2024 | The c.1060G>A (p.V354I) alteration is located in exon 8 (coding exon 8) of the PRSS53 gene. This alteration results from a G to A substitution at nucleotide position 1060, causing the valine (V) at amino acid position 354 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at